ESTIMATION OF THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN THE FORM OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC PANCREATITIS USING THE NAFLD FIBROSIS SCORE INDEX
Introduction: Non-alcoholic fatty liver disease (NAFLD), which develops against the background of type 2 diabetes mellitus, obesity and arterial hypertension, has become one of the most common chronic metabolic diseases in recent years. The presence of fatty liver or NAFLD in pancreatitis occurs with a prevalence of 18 to 43%, which in turn aggravated the course of pancreatitis.
Aim: To study the prevalence of non-alcoholic fatty liver disease in the form of liver fibrosis using the NAFLD Fibrosis Score.
Materials and methods: Study design - a single-stage retrospective cross-sectional study. Inclusion criteria: males and females aged 18 to 75 years with a confirmed diagnosis of non-alcoholic fatty liver disease in patients who received inpatient treatment at the Gastroenterology Department of the University Hospital of NJSC "Semey Medical University" in the period 01.01.2021 to 12.31.2022. Exclusion criteria: presence malignant neoplasms; pregnancy, lactation. Liver fibrosis was assessed by the NAFLD Fibrosis Score.
Results: When studying the average values of the NAFLD Fibrosis Score by sex, BMI, a statistically significant difference was revealed. When studying the distribution of risk factors according to the degree of liver fibrosis, an associative relationship was found with BMI (p=0.001). The chance of developing liver fibrosis, regardless of the degree of fibrosis, increased in patients with overweight and obesity by 2.94 times (95% CI: 1.67-5.3) (p=0.001) compared with those who had normal BMI. The ROC-analysis with the construction of ROC-curves revealed the relationship between the prognosis of the degree of liver fibrosis and BMI indices p=0.0001. With an equal BMI or higher, a high risk of developing liver fibrosis was predicted. The sensitivity and specificity of the method were 95% and 76.9%, respectively. Also, correlations were found between the prognosis of the degree of liver fibrosis and age, p=0.0001. At an equal or greater age, a high risk of developing liver fibrosis was predicted. The sensitivity and specificity of the method were 98.8% and 79.3%, respectively.
Conclusions: Thus, the use of the NAFLD Fibrosis Score in practice will allow timely and inexpensive detection of the presence of liver fibrosis after the age of 35 years and with a BMI above 22.76.
Number of Views: 128
Category of articles:
Original articles
Bibliography link
Shakhanova A.T., Zhumadilova Z.K., Kaskabaeva A.Sh., Shakhanov T.E., Zhylkybaeva K.Sh., Muzdubaev D.K. Estimation of the prevalence of non-alcoholic fatty liver disease in the form of liver fibrosis in patients with chronic pancreatitis using the NAFLD Fibrosis Score index // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 1, pp. 67-73. doi 10.34689/SH.2023.25.1.008Related publications:
A COMPARATIVE ANALYSIS OF 24-HOUR DIETARY RECALLS AND FOOD FREQUENCY QUESTIONNAIRES ADMINISTERED SIMULTANEOUSLY IN THE KAZAKHSTANI POPULATION
ANALYSIS OF PATIENT SATISFACTION WITH THE QUALITY OF ORGANIZATION OF TREATMENT IN FOREIGN CLINICS
CLINICAL AND LABORATORY PREDICTORS OF THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
POST-MARKETING STUDY OF THE CLINICAL EFFICACY AND SAFETY OF GRIPMAX NOS IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT
EXPERIENCE IN IMPROVING SURGICAL TREATMENT WHEN IMPOSING A STOMA IN CHILDREN WITH HIRSPRUNG'S DISEASE